Maybe, maybe not as no reference was made to diet history of patients nor their weight and exercise ability (just that they had some degree of blockage or occlusion of a main artery and that may have been the factor the caused 'chest pains'). There was also no mention of any other meds that patient was taking currently (like anxiety or other psych medicated conditions). Low threshold inflammation allergy can manifest itself in the
equation also, and not having been addressed as source contributing to
'chest pains'. There was no reference to stress factors in the patients life and environment.
Best to seek alternatives to surgery beforehand and if the patient is finely at a stage wherein 'chest pains' manifest, operative measures are usually quickest way to alleviate a stat medical threat to patient and their condition? Be this so, CVRS is still 'in-the-game' of improving
operative outcomes.
As the article alluded to, the vast surgery operations numbers worldwide are not going to be halted, without further supporting research studies. One might suspect however; that meds panels given to patient will be more closely watched and adjusted thus. One cannot fault the surgeon doctor, unless they have not adequately made observation of surrounding tissues and blood flow states. And, this may just be impossible in an emergent medical situation. Stents may be all there is left, before mechanical pumps and electronic valves and boosters to heart beat are needed? And, genetics plays a role also. Thus, operative procedures can try and beat 'your genes' monkey wrench thrown in to the medical equation.
It is not pleasant to watch our stock price daily fall a stead bit, and why this is so is basically unknown. As a reference I sold out my small
stock position and am now watching for entry when it bottom signals a new support bases.
